Perceptive Advisors’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-263,207
| Closed | -$22.8M | – | 91 |
|
|
2023
Q2 | $22.8M | Sell |
263,207
-409,853
| -61% | -$35.5M | 0.66% | 46 |
|
|
2023
Q1 | $65.4M | Buy |
673,060
+166,579
| +33% | +$16.2M | 1.93% | 13 |
|
|
2022
Q4 | $52.4M | Buy |
506,481
+170,000
| +51% | +$17.6M | 1.47% | 21 |
|
|
2022
Q3 | $28.5M | Buy |
336,481
+156,481
| +87% | +$13.3M | 0.83% | 32 |
|
|
2022
Q2 | $14.9M | Buy |
+180,000
| New | +$14.9M | 0.47% | 47 |
|
|
2022
Q1 | – | Sell |
-1,180,000
| Closed | -$104M | – | 140 |
|
|
2021
Q4 | $104M | Buy |
+1,180,000
| New | +$104M | 1.61% | 17 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 113 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 108 |
|
|
2017
Q2 | – | Sell |
-250
| Closed | -$22K | – | 132 |
|
|
2017
Q1 | $22K | Hold |
250
| – | – | ﹤0.01% | 139 |
|
|
2016
Q4 | $21K | Hold |
250
| – | – | ﹤0.01% | 153 |
|
|
2016
Q3 | $23K | Buy |
+250
| New | +$23K | ﹤0.01% | 175 |
|